Thomas Powles is Professor of Genitourinary Oncology at the University of London and Director of the Cancer Research UK Barts Centre at St Bartholomew’s Hospital, one of the UK’s largest Cancer Centres, in London, UK. He trained as an oncologist at Imperial College, London. His MD thesis was on mechanisms of resistance to systemic therapy in urological cancers.
Prof. Powles’ research interests are in the development of biomarkers and new drug strategies in urological cancers; in this role he been responsible for multiple EMA and FDA approvals, and has led a number of clinical trials and translational oncology projects (both university-led and industry-sponsored studies) that have been reported in major journals.
In addition to his research interests, Prof. Powles leads the European Society for Medical Oncology (ESMO) guidelines committees for renal and bladder cancer. He has previously participated in steering committees for the educational and scientific tracks for ESMO meetings; he co-chaired the ESMO Immuno-Oncology congress from 2019 to 2021, and served as the track chair for ESMO’s Genitourinary Tumours (Non-Prostate) meeting in 2021.
Prof. Powles has presented in his chosen field at most of the major meetings and congresses, and was awarded the Bladder Cancer Award at the ASCO Genitourinary Cancers Symposium (ASCO GU) in 2018. He has an active role on social media, with more than 50,000 podcast listeners and more than 3000 followers on Twitter.
EM-105183 - Date of preparation: July 2022